Nuclear Magnetic Resonance

The facility combines Covance Drug Development and LabCorp Diagnostics capabilities. (Photo: Business Wire)

Covance opens companion diagnostics laboratory

By Melissa Fassbender

LabCorp’s Covance has opened a new companion diagnostics laboratory as is prepares for an increasing demand for precision medicine – a market expected to reach $112.62bn by 2025.

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All suppliers